Disease activities and serum C-reactive protein levels in patients with vasospastic angina pectoris

Journal of Cardiology

Volumn 46, Issue 2, 2005, Pages 63-70

  Katayama, Naoyuki ^a   Nakao, Koichi ^a   Horiuchi, Kenji ^a   Kasanuki, Hiroshi ^b   Honda, Takashi ^a  

^a SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Angina pectoris (C reactive protein); Coronary vasospasm; Endothelium

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; DISEASE ACTIVITY; ELECTROCARDIOGRAPHY; HUMAN; PROTEIN BLOOD LEVEL; PROVOCATION TEST; REVIEW; VASOSPASM;

ACETYLCHOLINE; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY VASOSPASM; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 24344465902     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051
2. Chester AH, O'Neil GS, Moncada S, Tadjkarimi S, Yacoub MH: Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries. Lancet 1990; 336: 897-900
3. Zeiher AM, Drexler H, Wollschlager H, Just H: Modulation of coronary vasomotor tone in humans: Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401
4. Arbustini E, Grasso M, Diegoli M, Bellini O, Ohio S, De Servi S, Martinelli L, Vigano M, Specchia G: Morphologic changes induced by acetylcholine infusion in normal and atherosclerotic coronary arteries. Am J Cardiol 1993; 71: 1382-1390
5. Reddy KG, Nair RV, Sheehan HM, Hodgson JM: Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 1994; 23: 833-843
6. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454
7. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A: Immune system activation follows inflammation in unstable angina: Pathogenetic implications. J Am Coll Cardiol 1998; 32: 1295-1304
8. Berk BC, Weintraub WS, Alexander RW: Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol 1990; 65: 168-172
9. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB: A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51(4 Suppl): 5-40
10. van der War AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44
11. Ross R: Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126
12. Umemoto S, Suzuki N, Fujii K, Fujii A, Fujii T, Iwami T, Ogawa H, Matsuzaki M: Eosinophil counts and plasma fibrinogen in patients with vasospastic angina pectoris. Am J Cardiol 2000; 85: 715-719
13. Tomimura M, Saitoh T, Kishida H, Kusama Y, Takano T: Clinical significance of plasma concentration of macrophage colony-stimulating factor in patients with vasospastic angina. J Cardiol 2002; 39: 19-27 (in Jpn with Eng abstr)
14. Hung MJ, Cherng WJ, Cheng CW, Yang NI: Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrates) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Am J Cardiol 2005; 95: 84-87
15. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, Matsuyama K: Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12: 883-888
16. Okumura K, Yasue H, Horio Y, Takaoka K, Matsuyama K, Kugiyama K, Fujii H, Morikami Y: Multivessel coronary spasm in patients with variant angina: A study with intracoronary injection of acetylcholine. Circulation 1988; 77: 535-542
17. Ogawa H, Suefuji H, Takazoe K, Soejima H, Sakamoto T, Miyamoto S, Kaikita K, Yoshimura M, Kugiyama K, Yasue H: Difference in fibrinolytic activity between multivessel coronary spasm and one-vessel coronary spasm. Am J Cardiol 2000; 85: 98-101
18. Werns SW, Walton JA, Hsia HH, Nabel EG, Sanz ML, Pitt B: Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation 1989; 79: 287-291
19. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H: Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment: Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482-490
20. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, Sumida H, Fujii H, Matsunaga T, Tsunoda R: Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina: Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996; 27: 45-52
21. Fujii H, Yasue H, Okumura K, Matsuyama K, Morikami Y, Miyagi H, Ogawa H: Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: An echocardiographic and arteriographic study. J Am Coll Cardiol 1988; 12: 1184-1192
22. Onaka H, Hirota Y, Shimada S, Kita Y, Sakai Y, Kawakami Y, Suzuki S, Kawamura K: Clinical observation of spontaneous anginal attacks and multivessel spasm in variant angina pectoris with normal coronary artries: Evaluation by 24-hour 12-lead electrocardiography with computer analysis. J Am Coll Cardiol 1996; 27: 38-44
23. Onaka H, Hirota Y, Shimada S, Suzuki S, Kono T, Suzuki J, Sakai Y, Kawamura K: Prognostic significance of the pattern of multivessel spasm in patients with variant angina. Jpn Circ J 1999; 63: 509-513
24. Yasue H, Takizawa A, Nagao M, Nishida S, Horie M, Kubota J, Omote S, Takaoka K, Okumura K: Long-term prognosis for patients with variant angina and influential factors. Circulation 1988; 78: 1-9
25. Miller DD, Waters DD, Szlachcic J, Theroux P: Clinical characteristics associated with sudden death in patients with variant angina. Circulation 1982; 66: 588-592
26. MacAlpin RN: Cardiac arrest and sudden death unexpected death in variant angina: Complications of coronary spasm that can occur in the absence of severe organic coronary stecosis. Am Heart J 1993; 125: 1011-1017
27. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, Gioffre PA: Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol 1998; 82: 515-518
28. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol 2000; 85: 92-95
29. Ridker PM, Rifai N, Lowenthal SP: Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation 2001; 103: 1191-1193
30. Albert MA, Danielson E, Rifai N, Ridker PM, PRINCE Investigators: Effect of satin therapy on C-reactive protein levels: The pravastatin inflammation/CRP evaluation (PRINCE): A randomized trial and cohort study. JAMA 2001; 286: 64-70
31. Plenge JK, Hernandez TL, Weil KM, Poirier P, Grunwald GK, Marcovina SM, Eckel RH: Simvastatin lowers C-reactive protein within 14 days: An effect independent of low-density lipoprotein cholesterol reduction. Circulation 2002; 106: 1447-1452
32. Zhang YX, Cliff WJ, Schoelf GI, Higgins G: Coronary C-reactive protein distribution: Its relation to development of atherosclerosis. Atherosclerosis 1999; 145: 375-379
33. Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 1386-1392
34. Pasceri V, Willerson JT, Yeh ETH: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168
35. Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J: C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocytes recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 2000; 20: 2094-2099
36. Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation 2001; 103: 1194-1197